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Figure 1: Post-contrast axial CT image, showing hypodense mural thickening of the caecum (arrow), with irregular contrast enhancement of the 
endoluminal surface.
A 57-year-old Caucasian male with a history of diffuse large B-
cell non-Hodgkin’s lymphoma (NHL), who underwent many 
different cycles of immunochemotherapy during the period 
May–December 2009, was referred to our Institution for 
asthenia, abdominal pain and fever. He had remarkable 
haematological examinations: WC 0.01x10 3, HB 7.0, PLT 
11000, CRP 49 mg/l, ESR 105, LDH 488 UI/l. 
A bone marrow biopsy indicated relapse of NHL and a 
computed tomography (CT) scan of chest-abdomen and pelvis 
showed enlarged mediastinal and retroperitoneal lymph nodes, 
an enlarged spleen and a massive hypodense mural thickening 
of the caecum (Figure 1) and ascending colon (Figure 2). 
Typhlitis, a transmural inflammation of the caecum, often with 
involvement of the ascending colon and ileum, was suspected. 
A faecal culture was negative for C. difficile. The patient was 
treated with antibiotics, fluids and steroids, resulting in a 
regression of phlogosis indices in two weeks. Due to fever 
persistence, interpreted as a sign of disease progression, the 
patient was thereafter given a further cycle of chemo- 
therapy. 
Typhlitis, also known as neutropenic enterocolitis, occurs 
primarily in severely immunosuppressed patients undergoing 
chemotherapy for haematological [1] and solid tumours, 
including breast, lung, colorectal and ovarian cancer [2,3]. 
However, individuals at risk of developing typhlitis extend 
beyond oncologic patients. The underlying problem in all of 
these patients is the existence of absolute neutropenia. Early 
recognition of typhlitis is paramount to a potentially good 
outcome as the mortality rate for typhlitis can be as high as 
40%–50%, mostly because it is frequently associated with 
bowel perforation, if left undiagnosed. 
Diagnosis is based on imaging and clinical findings, after 
excluding other pathologies. Neutropenic patients, presenting 
with either generalized or focal abdominal pain, accompanied 
by fever, should be considered at risk of typhlitis [3]. The best 
imaging clue from a CT scan is a hypodense circumferential 
wall thickening of caecum and/or ascending colon (due oedema 
of the wall) frequently associated with pericolonic inflammation. 
Treatment including bowel rest, broad-spectrum antibiotics and 
haemodynamic support, especially if started early, should lead 
to a prompt remission of symptoms and survival of the patient. 
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Figure 2: Post-contrast coronal reconstruction, showing the mural thickening extending from the caecum to the ascending colon (arrow).
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